Menu Bar

Home           Calendar           Topics          Just Charlestown          About Us

Monday, January 6, 2025

New reports sharpen clinical picture of recent human H5N1 illnesses in US and Canada

Mutations? Not good.

Lisa Schnirring

Two groups of investigators today fleshed out fuller clinical understanding of North American patients recently infected with H5N1 avian influenza, one of them describing a Canadian teen who had a severe infection and the other reviewing illness features of 46 US patients, most of whom had mild infections following exposure to sick dairy cows or poultry.

The teams published their reports in the New England Journal of Medicine (NEJM).

In the final months of 2024, US health officials continue to battle outbreaks in dairy cattle from the B3.13 genotype, with sporadic spillovers to people and fallout from contamination in raw milk. The United States and Canada are now juggling a steep rise in poultry outbreaks from a different genotype carried by wild birds migrating south, which have been linked two severe human infections—one on each side of the border—and a spate of deaths in US cats.

Canadian teen had high viral loads, lower airway sample showed mutations

In one of the reports, Canadian researchers described clinical findings from a Canadian teen who contracted a severe infection from an undetermined source. The 13-year-old girl has mild asthma and elevated body mass index. She was first seen at an emergency department (ED) after a 2-day history of conjunctivitis in both eyes and a 1-day history of fever, then was sent home without treatment.

Her condition worsened, and 3 days later she returned to the ED in respiratory distress and hemodynamic instability and was admitted to the intensive care unit. The initial nasopharyngeal swab was positive for influenza A, but not the seasonal subtype. Further testing suggested a high viral load with a novel influenza A infection, which was found to be H5 avian influenza. The following day she was started on oseltamivir.

After her respiratory function deteriorated further, she was intubated and placed on extracorporeal membrane oxygenation (ECMO). Doctors also added combination antiviral treatment, which included baloxavir and amantadine.

Over the next few days, serial PCR testing showed declining viral loads. However, lower respiratory samples showed higher viral loads than those from upper-airway samples. Sequencing from a lower-airway isolate obtained 8 days after symptom onset identified three mutations potentially linked to enhanced virulence and human adaptation: E627K in the polymerase basic 2 gene, along with E186D and Q222H in the H5 hemagglutinin gene. Further analysis found that the virus belonged to the D1.1 genotype that was closely related to the virus circulating in British Columbia’s wild birds at the time.

When the patient’s respiratory status improved, her medical team discontinued ECMO on November 22 and extubated her on November 28.

US farm worker cases mild and self-limiting

In the other report, a team from the US Centers for Disease Control and Prevention (CDC) and collaborators in six states analyzed data from a standardized case-report form that was linked to the CDC’s H5 subtyping kits. Though the CDC has recorded 66 confirmed human cases this year, today’s report covers illnesses reported from March through October.

Of the 46 patients, all but one—a resident of Missouri who was hospitalized—was exposed to dairy cattle or poultry. Twenty-five had been exposed to infected or likely infected dairy cattle and 20 were exposed to sick poultry.

All of the people with animal exposure had mild illnesses, and none were hospitalized. All but three (93%) had conjunctivitis, about half (49%) had fever, and just over a third (36%) had respiratory symptoms. For 15 (33%) of the patients, conjunctivitis was the only symptom. Most patients received oseltamivir, which was started a median of 2 days after symptoms began.

No related cases were found among 97 contacts of patients who had animal exposures.

When researchers looked at the type of personal protective equipment (PPE) animal workers used, they found only 71% used gloves, 60% used eye protection, and 47% wore face masks. “PPE use among occupationally exposed persons was suboptimal, which suggests that additional strategies are needed to reduce exposure risk,” the authors wrote.

Lingering questions, deep concerns about preparedness

In an editorial in the same NEJM issue, two experts from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) weighed in on both reports. The authors are Michael Ison, MD, with the respiratory diseases branch of the division of microbiology and infectious diseases, and Jeanne Marrazzo, MD, MPH, the group’s director.

Regarding the Canadian patient, they said it’s not clear if the mutations were present in the virus that infected the girl or emerged during her illness course.

They said both reports shine a light on critical features of the threat to human health and response options. They said the US report exemplifies collaboration between human and animal health providers, public health leadership, and occupational health authorities. The standard surveillance approach is geared toward detecting novel cases, they noted. “This approach involves cultivating trust not only among numerous entities but with people seeking care for symptoms of concern, including conjunctivitis,” they wrote.

Meanwhile, the Canadian case underscores the urgent need to monitor for mutations, Ison and Marrazzo said. However, they pointed out that genomic sequencing from animals often lacks the metadata, making it difficult to track phylogenetic linkages and how the virus is spreading.

They also noted that the prolonged virus shedding that the Canadian team found highlights the need for longer antiviral therapy, which was recently reflected in updated CDC recommendations.